{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:58:03Z","timestamp":1794362283745,"version":"4.9.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100013301","name":"Parkinson's Foundation","doi-asserted-by":"publisher","award":["PF-PRF-1244721"],"award-info":[{"award-number":["PF-PRF-1244721"]}],"id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AG072979"],"award-info":[{"award-number":["P30AG072979"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AG072958"],"award-info":[{"award-number":["P30AG072958"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG084216"],"award-info":[{"award-number":["R21AG084216"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS064934"],"award-info":[{"award-number":["R01NS064934"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS119528"],"award-info":[{"award-number":["R01NS119528"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-025-02951-x","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:15:29Z","timestamp":1761225329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["LRRK2 kinase-mediated accumulation of lysosome-associated phospho-Rabs in tauopathies and synucleinopathies"],"prefix":"10.1007","volume":"150","author":[{"given":"Silas A.","family":"Buck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuyana","family":"Malankhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Strader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen B.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison W.","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ervin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hsiu J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie H.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"2951_CR1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/mds.29449","volume":"38","author":"J Agin-Liebes","year":"2023","unstructured":"Agin-Liebes J, Hickman RA, Vonsattel JP, Faust PL, Flowers X, Utkina Sosunova I et al (2023) Patterns of TDP-43 deposition in brains with LRRK2 G2019S mutations. Mov Disord 38:1541\u20131545. https:\/\/doi.org\/10.1002\/mds.29449","journal-title":"Mov Disord"},{"key":"2951_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-biochem-030122-051144","volume":"93","author":"DR Alessi","year":"2024","unstructured":"Alessi DR, Pfeffer SR (2024) Leucine-rich repeat kinases. Annu Rev Biochem 93:261\u2013287. https:\/\/doi.org\/10.1146\/annurev-biochem-030122-051144","journal-title":"Annu Rev Biochem"},{"key":"2951_CR3","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC","edition":"4"},{"key":"2951_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00401-013-1188-4","volume":"126","author":"RM Bailey","year":"2013","unstructured":"Bailey RM, Covy JP, Melrose HL, Rousseau L, Watkinson R, Knight J et al (2013) LRRK2 phosphorylates novel tau epitopes and promotes tauopathy. Acta Neuropathol 126:809\u2013827. https:\/\/doi.org\/10.1007\/s00401-013-1188-4","journal-title":"Acta Neuropathol"},{"key":"2951_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2025.102482","volume":"93","author":"A Bentley-DeSousa","year":"2025","unstructured":"Bentley-DeSousa A, Clegg D, Ferguson SM (2025) LRRK2, lysosome damage, and Parkinson\u2019s disease. Curr Opin Cell Biol 93:102482. https:\/\/doi.org\/10.1016\/j.ceb.2025.102482","journal-title":"Curr Opin Cell Biol"},{"key":"2951_CR6","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202310150","author":"A Bentley-DeSousa","year":"2025","unstructured":"Bentley-DeSousa A, Roczniak-Ferguson A, Ferguson SM (2025) A STING-CASM-GABARAP pathway activates LRRK2 at lysosomes. J Cell Biol. https:\/\/doi.org\/10.1083\/jcb.202310150","journal-title":"J Cell Biol"},{"key":"2951_CR7","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.50416","author":"K Berndsen","year":"2019","unstructured":"Berndsen K, Lis P, Yeshaw WM, Wawro PS, Nirujogi RS, Wightman M et al (2019) PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins. Elife. https:\/\/doi.org\/10.7554\/eLife.50416","journal-title":"Elife"},{"key":"2951_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbadis.2008.09.015","volume":"1792","author":"S Biskup","year":"2009","unstructured":"Biskup S, West AB (2009) Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson\u2019s disease. Biochim Biophys Acta 1792:625\u2013633. https:\/\/doi.org\/10.1016\/j.bbadis.2008.09.015","journal-title":"Biochim Biophys Acta"},{"key":"2951_CR9","doi-asserted-by":"publisher","first-page":"214 e211","DOI":"10.1016\/j.neurobiolaging.2018.11.007","volume":"76","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat C, Pletnikova O, Geiger JT, Murphy NA, Abramzon Y, Rudow G et al (2019) Genetic analysis of neurodegenerative diseases in a pathology cohort. Neurobiol Aging 76:214 e211-214 e219. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.11.007","journal-title":"Neurobiol Aging"},{"key":"2951_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb2454","author":"L Bonet-Ponce","year":"2020","unstructured":"Bonet-Ponce L, Beilina A, Williamson CD, Lindberg E, Kluss JH, Saez-Atienzar S et al (2020) LRRK2 mediates tubulation and vesicle sorting from lysosomes. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abb2454","journal-title":"Sci Adv"},{"key":"2951_CR11","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1042\/BST20240087","volume":"52","author":"L Bonet-Ponce","year":"2024","unstructured":"Bonet-Ponce L, Kluss JH, Cookson MR (2024) Mechanisms of lysosomal tubulation and sorting driven by LRRK2. Biochem Soc Trans 52:1909\u20131919. https:\/\/doi.org\/10.1042\/BST20240087","journal-title":"Biochem Soc Trans"},{"key":"2951_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259. https:\/\/doi.org\/10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"key":"2951_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Braak E (1995) Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging 16:271\u2013278. https:\/\/doi.org\/10.1016\/0197-4580(95)00021-6","journal-title":"Neurobiol Aging"},{"key":"2951_CR14","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.101135.1","author":"B Brahmia","year":"2024","unstructured":"Brahmia B, Naaldijk Y, Sarkar P, Parisiadou L, Hilfiker S (2024) Pathogenic LRRK2 causes age-dependent and region-specific deficits in ciliation, innervation and viability of cholinergic neurons. Elife. https:\/\/doi.org\/10.7554\/eLife.101135.1","journal-title":"Elife"},{"key":"2951_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00609-7","volume":"9","author":"M Bu","year":"2023","unstructured":"Bu M, Follett J, Deng I, Tatarnikov I, Wall S, Guenther D et al (2023) Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine physiology in VPS35 p. D620N knock-in mice. NPJ Parkinsons Dis 9:167. https:\/\/doi.org\/10.1038\/s41531-023-00609-7","journal-title":"NPJ Parkinsons Dis"},{"key":"2951_CR16","doi-asserted-by":"publisher","first-page":"18952","DOI":"10.1074\/jbc.RA119.009432","volume":"294","author":"JJ Chen","year":"2019","unstructured":"Chen JJ, Nathaniel DL, Raghavan P, Nelson M, Tian R, Tse E et al (2019) Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation. J Biol Chem 294:18952\u201318966. https:\/\/doi.org\/10.1074\/jbc.RA119.009432","journal-title":"J Biol Chem"},{"key":"2951_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.parkreldis.2020.09.030","volume":"80","author":"KS Chin","year":"2020","unstructured":"Chin KS, Yassi N, Churilov L, Masters CL, Watson R (2020) Prevalence and clinical associations of tau in Lewy body dementias: a systematic review and meta-analysis. Parkinsonism Relat Disord 80:184\u2013193. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.09.030","journal-title":"Parkinsonism Relat Disord"},{"key":"2951_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-021-00476-x","volume":"16","author":"DC Chung","year":"2021","unstructured":"Chung DC, Roemer S, Petrucelli L, Dickson DW (2021) Cellular and pathological heterogeneity of primary tauopathies. Mol Neurodegener 16:57. https:\/\/doi.org\/10.1186\/s13024-021-00476-x","journal-title":"Mol Neurodegener"},{"key":"2951_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae404","author":"A Cortes","year":"2024","unstructured":"Cortes A, Phung TK, de Mena L, Garrido A, Infante J, Ruiz-Martinez J et al (2024) In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson\u2019s disease. Brain. https:\/\/doi.org\/10.1093\/brain\/awae404","journal-title":"Brain"},{"key":"2951_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ana.25392","volume":"85","author":"D Coughlin","year":"2019","unstructured":"Coughlin D, Xie SX, Liang M, Williams A, Peterson C, Weintraub D et al (2019) Cognitive and pathological influences of Tau pathology in Lewy body disorders. Ann Neurol 85:259\u2013271. https:\/\/doi.org\/10.1002\/ana.25392","journal-title":"Ann Neurol"},{"key":"2951_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/mds.22096","volume":"24","author":"JP Covy","year":"2009","unstructured":"Covy JP, Yuan W, Waxman EA, Hurtig HI, Van Deerlin VM, Giasson BI (2009) Clinical and pathological characteristics of patients with leucine-rich repeat kinase-2 mutations. Mov Disord 24:32\u201339. https:\/\/doi.org\/10.1002\/mds.22096","journal-title":"Mov Disord"},{"key":"2951_CR22","doi-asserted-by":"publisher","first-page":"19433","DOI":"10.1074\/jbc.M115.660001","volume":"290","author":"JP Daher","year":"2015","unstructured":"Daher JP, Abdelmotilib HA, Hu X, Volpicelli-Daley LA, Moehle MS, Fraser KB et al (2015) Leucine-rich repeat kinase 2 (LRRK2) pharmacological inhibition abates alpha-synuclein gene-induced neurodegeneration. J Biol Chem 290:19433\u201319444. https:\/\/doi.org\/10.1074\/jbc.M115.660001","journal-title":"J Biol Chem"},{"key":"2951_CR23","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.87098","author":"HS Dhekne","year":"2023","unstructured":"Dhekne HS, Tonelli F, Yeshaw WM, Chiang CY, Limouse C, Jaimon E et al (2023) Genome-wide screen reveals Rab12 GTPase as a critical activator of Parkinson\u2019s disease-linked LRRK2 kinase. Elife. https:\/\/doi.org\/10.7554\/eLife.87098","journal-title":"Elife"},{"key":"2951_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar5429","author":"R Di Maio","year":"2018","unstructured":"Di Maio R, Hoffman EK, Rocha EM, Keeney MT, Sanders LH, De Miranda BR et al (2018) LRRK2 activation in idiopathic Parkinson\u2019s disease. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aar5429","journal-title":"Sci Transl Med"},{"key":"2951_CR25","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/brain\/awaa223","volume":"143","author":"E Drummond","year":"2020","unstructured":"Drummond E, Pires G, MacMurray C, Askenazi M, Nayak S, Bourdon M et al (2020) Phosphorylated tau interactome in the human Alzheimer\u2019s disease brain. Brain 143:2803\u20132817. https:\/\/doi.org\/10.1093\/brain\/awaa223","journal-title":"Brain"},{"key":"2951_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40035-025-00494-5","volume":"14","author":"DJ Dues","year":"2025","unstructured":"Dues DJ, Erb ML, Kasen A, Vatsa N, Williams ET, Nguyen APT et al (2025) Pathological alpha-synuclein elicits granulovacuolar degeneration independent of tau. Transl Neurodegener 14:31. https:\/\/doi.org\/10.1186\/s40035-025-00494-5","journal-title":"Transl Neurodegener"},{"key":"2951_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106338","author":"DJ Dues","year":"2023","unstructured":"Dues DJ, Ma Y, Nguyen APT, Offerman AV, Beddows I, Moore DJ (2023) Formation of templated inclusions in a forebrain alpha-synuclein mouse model is independent of LRRK2. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2023.106338","journal-title":"Neurobiol Dis"},{"key":"2951_CR28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3389\/fnins.2020.00719","volume":"14","author":"DJ Dues","year":"2020","unstructured":"Dues DJ, Moore DJ (2020) LRRK2 and protein aggregation in Parkinson\u2019s disease: insights from animal models. Front Neurosci 14:719. https:\/\/doi.org\/10.3389\/fnins.2020.00719","journal-title":"Front Neurosci"},{"key":"2951_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/mds.26892","volume":"32","author":"N Dzamko","year":"2017","unstructured":"Dzamko N, Gysbers AM, Bandopadhyay R, Bolliger MF, Uchino A, Zhao Y et al (2017) LRRK2 levels and phosphorylation in Parkinson\u2019s disease brain and cases with restricted Lewy bodies. Mov Disord 32:423\u2013432. https:\/\/doi.org\/10.1002\/mds.26892","journal-title":"Mov Disord"},{"key":"2951_CR30","doi-asserted-by":"publisher","first-page":"E9115","DOI":"10.1073\/pnas.1812196115","volume":"115","author":"T Eguchi","year":"2018","unstructured":"Eguchi T, Kuwahara T, Sakurai M, Komori T, Fujimoto T, Ito G et al (2018) LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis. Proc Natl Acad Sci U S A 115:E9115\u2013E9124. https:\/\/doi.org\/10.1073\/pnas.1812196115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2951_CR31","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22:1689\u20131707. https:\/\/doi.org\/10.1002\/mds.21507","journal-title":"Mov Disord"},{"key":"2951_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-025-00514-0","author":"LD Evans","year":"2025","unstructured":"Evans LD, Strano A, Tuck E, Campbell A, Smith J, Hung C et al (2025) Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2. EMBO J. https:\/\/doi.org\/10.1038\/s44318-025-00514-0","journal-title":"EMBO J"},{"key":"2951_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1042\/BCJ20170803","volume":"475","author":"Y Fan","year":"2018","unstructured":"Fan Y, Howden AJM, Sarhan AR, Lis P, Ito G, Martinez TN et al (2018) Interrogating Parkinson\u2019s disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils. Biochem J 475:23\u201344. https:\/\/doi.org\/10.1042\/BCJ20170803","journal-title":"Biochem J"},{"key":"2951_CR34","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00401-021-02325-z","volume":"142","author":"Y Fan","year":"2021","unstructured":"Fan Y, Nirujogi RS, Garrido A, Ruiz-Martinez J, Bergareche-Yarza A, Mondragon-Rezola E et al (2021) R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils. Acta Neuropathol 142:475\u2013494. https:\/\/doi.org\/10.1007\/s00401-021-02325-z","journal-title":"Acta Neuropathol"},{"key":"2951_CR35","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.3233\/JPD-213128","volume":"12","author":"B Fernandez","year":"2022","unstructured":"Fernandez B, Chittoor-Vinod VG, Kluss JH, Kelly K, Bryant N, Nguyen APT et al (2022) Evaluation of current methods to detect cellular Leucine-Rich Repeat Kinase 2 (LRRK2) kinase activity. J Parkinsons Dis 12:1423\u20131447. https:\/\/doi.org\/10.3233\/JPD-213128","journal-title":"J Parkinsons Dis"},{"key":"2951_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00401-023-02585-x","volume":"146","author":"J Garcia-Revilla","year":"2023","unstructured":"Garcia-Revilla J, Boza-Serrano A, Jin Y, Vadukul DM, Soldan-Hidalgo J, Camprubi-Ferrer L et al (2023) Galectin-3 shapes toxic alpha-synuclein strains in Parkinson\u2019s disease. Acta Neuropathol 146:51\u201375. https:\/\/doi.org\/10.1007\/s00401-023-02585-x","journal-title":"Acta Neuropathol"},{"key":"2951_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"DJ Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33\u201339. https:\/\/doi.org\/10.1001\/archneur.56.1.33","journal-title":"Arch Neurol"},{"key":"2951_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","volume":"23","author":"E Greggio","year":"2006","unstructured":"Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A et al (2006) Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin. Neurobiol Dis 23:329\u2013341. https:\/\/doi.org\/10.1016\/j.nbd.2006.04.001","journal-title":"Neurobiol Dis"},{"key":"2951_CR39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.bbrc.2009.08.163","volume":"389","author":"E Greggio","year":"2009","unstructured":"Greggio E, Taymans JM, Zhen EY, Ryder J, Vancraenenbroeck R, Beilina A et al (2009) The Parkinson\u2019s disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites. Biochem Biophys Res Commun 389:449\u2013454. https:\/\/doi.org\/10.1016\/j.bbrc.2009.08.163","journal-title":"Biochem Biophys Res Commun"},{"key":"2951_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.parkreldis.2016.07.015","volume":"31","author":"MG Heckman","year":"2016","unstructured":"Heckman MG, Soto-Ortolaza AI, Contreras MYS, Murray ME, Pedraza O, Diehl NN et al (2016) LRRK2 variation and dementia with Lewy bodies. Parkinsonism Relat Disord 31:98\u2013103. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.07.015","journal-title":"Parkinsonism Relat Disord"},{"key":"2951_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0836-x","volume":"7","author":"MX Henderson","year":"2019","unstructured":"Henderson MX, Sengupta M, Trojanowski JQ, Lee VMY (2019) Alzheimer\u2019s disease tau is a prominent pathology in LRRK2 Parkinson\u2019s disease. Acta Neuropathol Commun 7:183. https:\/\/doi.org\/10.1186\/s40478-019-0836-x","journal-title":"Acta Neuropathol Commun"},{"key":"2951_CR42","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jnen\/nlw070","volume":"75","author":"DH Hepp","year":"2016","unstructured":"Hepp DH, Vergoossen DL, Huisman E, Lemstra AW, Netherlands Brain B, Berendse HW et al (2016) Distribution and load of amyloid-beta pathology in Parkinson disease and dementia with lewy bodies. J Neuropathol Exp Neurol 75:936\u2013945. https:\/\/doi.org\/10.1093\/jnen\/nlw070","journal-title":"J Neuropathol Exp Neurol"},{"key":"2951_CR43","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020104494","volume":"39","author":"S Herbst","year":"2020","unstructured":"Herbst S, Campbell P, Harvey J, Bernard EM, Papayannopoulos V, Wood NW et al (2020) LRRK2 activation controls the repair of damaged endomembranes in macrophages. EMBO J 39:e104494. https:\/\/doi.org\/10.15252\/embj.2020104494","journal-title":"EMBO J"},{"key":"2951_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat3005","author":"I Hernandez","year":"2019","unstructured":"Hernandez I, Luna G, Rauch JN, Reis SA, Giroux M, Karch CM et al (2019) A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aat3005","journal-title":"Sci Transl Med"},{"key":"2951_CR45","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1080\/15548627.2018.1461294","volume":"14","author":"X Hou","year":"2018","unstructured":"Hou X, Fiesel FC, Truban D, Castanedes Casey M, Lin WL, Soto AI et al (2018) Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease. Autophagy 14:1404\u20131418. https:\/\/doi.org\/10.1080\/15548627.2018.1461294","journal-title":"Autophagy"},{"key":"2951_CR46","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/alz.12198","volume":"17","author":"X Hou","year":"2020","unstructured":"Hou X, Watzlawik JO, Cook C, Liu CC, Kang SS, Lin WL et al (2020) Mitophagy alterations in Alzheimer\u2019s disease are associated with granulovacuolar degeneration and early tau pathology. Alzheimers Dement 17:417\u2013430. https:\/\/doi.org\/10.1002\/alz.12198","journal-title":"Alzheimers Dement"},{"key":"2951_CR47","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/00005072-199812000-00009","volume":"57","author":"CM Hulette","year":"1998","unstructured":"Hulette CM, Welsh-Bohmer KA, Murray MG, Saunders AM, Mash DC, McIntyre LM (1998) Neuropathological and neuropsychological changes in \u201cnormal\u201d aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol 57:1168\u20131174. https:\/\/doi.org\/10.1097\/00005072-199812000-00009","journal-title":"J Neuropathol Exp Neurol"},{"key":"2951_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cells9112344","author":"L Iannotta","year":"2020","unstructured":"Iannotta L, Biosa A, Kluss JH, Tombesi G, Kaganovich A, Cogo S et al (2020) Divergent effects of G2019S and R1441C LRRK2 mutations on LRRK2 and Rab10 phosphorylations in mouse tissues. Cells. https:\/\/doi.org\/10.3390\/cells9112344","journal-title":"Cells"},{"key":"2951_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX et al (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16:55\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(16)30291-5","journal-title":"Lancet Neurol"},{"key":"2951_CR50","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.23659","volume":"72","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V et al (2012) Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 72:587\u2013598. https:\/\/doi.org\/10.1002\/ana.23659","journal-title":"Ann Neurol"},{"key":"2951_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1474-4422(20)30394-X","volume":"20","author":"E Jabbari","year":"2021","unstructured":"Jabbari E, Koga S, Valentino RR, Reynolds RH, Ferrari R, Tan MMX et al (2021) Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study. Lancet Neurol 20:107\u2013116. https:\/\/doi.org\/10.1016\/S1474-4422(20)30394-X","journal-title":"Lancet Neurol"},{"key":"2951_CR52","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1042\/BJ20070209","volume":"405","author":"M Jaleel","year":"2007","unstructured":"Jaleel M, Nichols RJ, Deak M, Campbell DG, Gillardon F, Knebel A et al (2007) LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson\u2019s disease mutants affect kinase activity. Biochem J 405:307\u2013317. https:\/\/doi.org\/10.1042\/BJ20070209","journal-title":"Biochem J"},{"key":"2951_CR53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00401-025-02871-w","volume":"149","author":"NM Jensen","year":"2025","unstructured":"Jensen NM, Vitic Z, Antorini MR, Viftrup TB, Parkkinen L, Jensen PH (2025) Abundant non-inclusion alpha-synuclein pathology in Lewy body-negative LRRK2-mutant cases. Acta Neuropathol 149:41. https:\/\/doi.org\/10.1007\/s00401-025-02871-w","journal-title":"Acta Neuropathol"},{"key":"2951_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.586731","volume":"13","author":"S Jiang","year":"2020","unstructured":"Jiang S, Bhaskar K (2020) Degradation and transmission of tau by autophagic-endolysosomal networks and potential therapeutic targets for tauopathy. Front Mol Neurosci 13:586731. https:\/\/doi.org\/10.3389\/fnmol.2020.586731","journal-title":"Front Mol Neurosci"},{"key":"2951_CR55","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13195-022-01128-y","volume":"14","author":"M Jorge-Oliva","year":"2022","unstructured":"Jorge-Oliva M, Smits JFM, Wiersma VI, Hoozemans JJM, Scheper W (2022) Granulovacuolar degeneration bodies are independently induced by tau and alpha-synuclein pathology. Alzheimers Res Ther 14:187. https:\/\/doi.org\/10.1186\/s13195-022-01128-y","journal-title":"Alzheimers Res Ther"},{"key":"2951_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","volume":"72","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW et al (2015) Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 72:100\u2013105. https:\/\/doi.org\/10.1001\/jamaneurol.2014.2704","journal-title":"JAMA Neurol"},{"key":"2951_CR57","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1042\/BCJ20200458","volume":"477","author":"AF Kalogeropulou","year":"2020","unstructured":"Kalogeropulou AF, Freemantle JB, Lis P, Vides EG, Polinski NK, Alessi DR (2020) Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity. Biochem J 477:4397\u20134423. https:\/\/doi.org\/10.1042\/BCJ20200458","journal-title":"Biochem J"},{"key":"2951_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147372","volume":"1759","author":"K Kelly","year":"2021","unstructured":"Kelly K, Chang A, Hastings L, Abdelmotilib H, West AB (2021) Genetic background influences LRRK2-mediated Rab phosphorylation in the rat brain. Brain Res 1759:147372. https:\/\/doi.org\/10.1016\/j.brainres.2021.147372","journal-title":"Brain Res"},{"key":"2951_CR59","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67900","author":"SS Khan","year":"2021","unstructured":"Khan SS, Sobu Y, Dhekne HS, Tonelli F, Berndsen K, Alessi DR et al (2021) Pathogenic LRRK2 control of primary cilia and Hedgehog signaling in neurons and astrocytes of mouse brain. Elife. https:\/\/doi.org\/10.7554\/eLife.67900","journal-title":"Elife"},{"key":"2951_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105769","volume":"170","author":"JH Kluss","year":"2022","unstructured":"Kluss JH, Bonet-Ponce L, Lewis PA, Cookson MR (2022) Directing LRRK2 to membranes of the endolysosomal pathway triggers RAB phosphorylation and JIP4 recruitment. Neurobiol Dis 170:105769. https:\/\/doi.org\/10.1016\/j.nbd.2022.105769","journal-title":"Neurobiol Dis"},{"key":"2951_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-018-0049-1","volume":"4","author":"JH Kluss","year":"2018","unstructured":"Kluss JH, Conti MM, Kaganovich A, Beilina A, Melrose HL, Cookson MR et al (2018) Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity. NPJ Parkinsons Dis 4:13. https:\/\/doi.org\/10.1038\/s41531-018-0049-1","journal-title":"NPJ Parkinsons Dis"},{"key":"2951_CR62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13024-021-00441-8","volume":"16","author":"JH Kluss","year":"2021","unstructured":"Kluss JH, Mazza MC, Li Y, Manzoni C, Lewis PA, Cookson MR et al (2021) Preclinical modeling of chronic inhibition of the Parkinson\u2019s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo. Mol Neurodegener 16:17. https:\/\/doi.org\/10.1186\/s13024-021-00441-8","journal-title":"Mol Neurodegener"},{"key":"2951_CR63","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00401-016-1562-0","volume":"132","author":"C Kohler","year":"2016","unstructured":"Kohler C (2016) Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology. Acta Neuropathol 132:339\u2013359. https:\/\/doi.org\/10.1007\/s00401-016-1562-0","journal-title":"Acta Neuropathol"},{"key":"2951_CR64","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nbd.2014.07.006","volume":"71","author":"C Kohler","year":"2014","unstructured":"Kohler C, Dinekov M, Gotz J (2014) Granulovacuolar degeneration and unfolded protein response in mouse models of tauopathy and Abeta amyloidosis. Neurobiol Dis 71:169\u2013179. https:\/\/doi.org\/10.1016\/j.nbd.2014.07.006","journal-title":"Neurobiol Dis"},{"key":"2951_CR65","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H et al (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131:87\u2013102. https:\/\/doi.org\/10.1007\/s00401-015-1509-x","journal-title":"Acta Neuropathol"},{"key":"2951_CR66","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13195-021-00808-5","volume":"13","author":"Y Le Guen","year":"2021","unstructured":"Le Guen Y, Belloy ME, Napolioni V, Eger SJ, Kennedy G, Tao R et al (2021) A novel age-informed approach for genetic association analysis in Alzheimer\u2019s disease. Alzheimers Res Ther 13:72. https:\/\/doi.org\/10.1186\/s13195-021-00808-5","journal-title":"Alzheimers Res Ther"},{"key":"2951_CR67","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1523\/JNEUROSCI.3809-03.2004","volume":"24","author":"HJ Lee","year":"2004","unstructured":"Lee HJ, Khoshaghideh F, Patel S, Lee SJ (2004) Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. J Neurosci 24:1888\u20131896. https:\/\/doi.org\/10.1523\/JNEUROSCI.3809-03.2004","journal-title":"J Neurosci"},{"key":"2951_CR68","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.1038\/s41467-024-52723-6","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Zhu H, Huang BT, Li X, Kim H, Tan H et al (2024) RAB12-LRRK2 complex suppresses primary ciliogenesis and regulates centrosome homeostasis in astrocytes. Nat Commun 15:8434. https:\/\/doi.org\/10.1038\/s41467-024-52723-6","journal-title":"Nat Commun"},{"key":"2951_CR69","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nn.2349","volume":"12","author":"Y Li","year":"2009","unstructured":"Li Y, Liu W, Oo TF, Wang L, Tang Y, Jackson-Lewis V et al (2009) Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson\u2019s disease. Nat Neurosci 12:826\u2013828. https:\/\/doi.org\/10.1038\/nn.2349","journal-title":"Nat Neurosci"},{"key":"2951_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BCJ20170802","volume":"475","author":"P Lis","year":"2018","unstructured":"Lis P, Burel S, Steger M, Mann M, Brown F, Diez F et al (2018) Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson\u2019s disease kinase. Biochem J 475:1\u201322. https:\/\/doi.org\/10.1042\/BCJ20170802","journal-title":"Biochem J"},{"key":"2951_CR71","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/hmg\/ddx410","volume":"27","author":"Z Liu","year":"2018","unstructured":"Liu Z, Bryant N, Kumaran R, Beilina A, Abeliovich A, Cookson MR et al (2018) LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network. Hum Mol Genet 27:385\u2013395. https:\/\/doi.org\/10.1093\/hmg\/ddx410","journal-title":"Hum Mol Genet"},{"key":"2951_CR72","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020104862","volume":"39","author":"Z Liu","year":"2020","unstructured":"Liu Z, Xu E, Zhao HT, Cole T, West AB (2020) LRRK2 and Rab10 coordinate macropinocytosis to mediate immunological responses in phagocytes. EMBO J 39:e104862. https:\/\/doi.org\/10.15252\/embj.2020104862","journal-title":"EMBO J"},{"key":"2951_CR73","doi-asserted-by":"publisher","first-page":"13621","DOI":"10.1074\/jbc.M109.074617","volume":"285","author":"SK Mak","year":"2010","unstructured":"Mak SK, McCormack AL, Manning-Bog AB, Cuervo AM, Di Monte DA (2010) Lysosomal degradation of alpha-synuclein in vivo. J Biol Chem 285:13621\u201313629. https:\/\/doi.org\/10.1074\/jbc.M109.074617","journal-title":"J Biol Chem"},{"key":"2951_CR74","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.brainres.2018.07.023","volume":"1701","author":"A Mamais","year":"2018","unstructured":"Mamais A, Manzoni C, Nazish I, Arber C, Sonustun B, Wray S et al (2018) Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson\u2019s disease brains with Lewy body pathology. Brain Res 1701:75\u201384. https:\/\/doi.org\/10.1016\/j.brainres.2018.07.023","journal-title":"Brain Res"},{"key":"2951_CR75","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology 89:88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058","journal-title":"Neurology"},{"key":"2951_CR76","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.nbd.2010.07.010","volume":"40","author":"HL Melrose","year":"2010","unstructured":"Melrose HL, Dachsel JC, Behrouz B, Lincoln SJ, Yue M, Hinkle KM et al (2010) Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice. Neurobiol Dis 40:503\u2013517. https:\/\/doi.org\/10.1016\/j.nbd.2010.07.010","journal-title":"Neurobiol Dis"},{"key":"2951_CR77","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1093\/hmg\/ddv105","volume":"24","author":"F Mikhail","year":"2015","unstructured":"Mikhail F, Calingasan N, Parolari L, Subramanian A, Yang L, Flint Beal M (2015) Lack of exacerbation of neurodegeneration in a double transgenic mouse model of mutant LRRK2 and tau. Hum Mol Genet 24:3545\u20133556. https:\/\/doi.org\/10.1093\/hmg\/ddv105","journal-title":"Hum Mol Genet"},{"key":"2951_CR78","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1042\/BCJ20180248","volume":"475","author":"R Mir","year":"2018","unstructured":"Mir R, Tonelli F, Lis P, Macartney T, Polinski NK, Martinez TN et al (2018) The Parkinson\u2019s disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human. Biochem J 475:1861\u20131883. https:\/\/doi.org\/10.1042\/BCJ20180248","journal-title":"Biochem J"},{"key":"2951_CR79","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/wnl.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486. https:\/\/doi.org\/10.1212\/wnl.41.4.479","journal-title":"Neurology"},{"key":"2951_CR80","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/alz.12749","volume":"19","author":"CM Moloney","year":"2023","unstructured":"Moloney CM, Labuzan SA, Crook JE, Siddiqui H, Castanedes-Casey M, Lachner C et al (2023) Phosphorylated tau sites that are elevated in Alzheimer\u2019s disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain. Alzheimers Dement 19:1029\u20131040. https:\/\/doi.org\/10.1002\/alz.12749","journal-title":"Alzheimers Dement"},{"key":"2951_CR81","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/alz.12321","volume":"17","author":"CM Moloney","year":"2021","unstructured":"Moloney CM, Lowe VJ, Murray ME (2021) Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: a clinicopathologic perspective for biomarker research. Alzheimers Dement 17:1554\u20131574. https:\/\/doi.org\/10.1002\/alz.12321","journal-title":"Alzheimers Dement"},{"key":"2951_CR82","doi-asserted-by":"publisher","DOI":"10.1101\/2025.06.02.657435","author":"CM Moloney","year":"2025","unstructured":"Moloney CM, Rutledge MH, Labuzan SA, Peng Z, Tranovich JF, Wood AC et al (2025) The neurofibrillary tangle maturity scale: a novel framework for tangle pathology evaluation in Alzheimer\u2019s disease. Biorxiv. https:\/\/doi.org\/10.1101\/2025.06.02.657435","journal-title":"Biorxiv"},{"key":"2951_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National institute on aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"key":"2951_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00817-0","volume":"20","author":"D Morderer","year":"2025","unstructured":"Morderer D, Wren MC, Liu F, Kouri N, Maistrenko A, Khalil B et al (2025) Probe-dependent proximity profiling (ProPPr) uncovers similarities and differences in phospho-tau-associated proteomes between tauopathies. Mol Neurodegener 20:32. https:\/\/doi.org\/10.1186\/s13024-025-00817-0","journal-title":"Mol Neurodegener"},{"key":"2951_CR85","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/brain\/awv050","volume":"138","author":"ME Murray","year":"2015","unstructured":"Murray ME, Lowe VJ, Graff-Radford NR, Liesinger AM, Cannon A, Przybelski SA et al (2015) Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer\u2019s disease spectrum. Brain 138:1370\u20131381. https:\/\/doi.org\/10.1093\/brain\/awv050","journal-title":"Brain"},{"key":"2951_CR86","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-022-02524-2","volume":"145","author":"PT Nelson","year":"2023","unstructured":"Nelson PT, Lee EB, Cykowski MD, Alafuzoff I, Arfanakis K, Attems J et al (2023) Late-NC staging in routine neuropathologic diagnosis: an update. Acta Neuropathol 145:159\u2013173. https:\/\/doi.org\/10.1007\/s00401-022-02524-2","journal-title":"Acta Neuropathol"},{"key":"2951_CR87","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/hmg\/ddx389","volume":"27","author":"APT Nguyen","year":"2018","unstructured":"Nguyen APT, Daniel G, Valdes P, Islam MS, Schneider BL, Moore DJ (2018) G2019s LRRK2 enhances the neuronal transmission of tau in the mouse brain. Hum Mol Genet 27:120\u2013134. https:\/\/doi.org\/10.1093\/hmg\/ddx389","journal-title":"Hum Mol Genet"},{"key":"2951_CR88","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/path.3969","volume":"226","author":"DA Nijholt","year":"2012","unstructured":"Nijholt DA, van Haastert ES, Rozemuller AJ, Scheper W, Hoozemans JJ (2012) The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies. J Pathol 226:693\u2013702. https:\/\/doi.org\/10.1002\/path.3969","journal-title":"J Pathol"},{"key":"2951_CR89","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3233\/JPD-191786","volume":"10","author":"S Padmanabhan","year":"2020","unstructured":"Padmanabhan S, Lanz TA, Gorman D, Wolfe M, Joyce A, Cabrera C et al (2020) An assessment of LRRK2 serine 935 phosphorylation in human peripheral blood mononuclear cells in idiopathic Parkinson\u2019s disease and G2019S LRRK2 cohorts. J Parkinsons Dis 10:623\u2013629. https:\/\/doi.org\/10.3233\/JPD-191786","journal-title":"J Parkinsons Dis"},{"key":"2951_CR90","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M et al (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 44:595\u2013600. https:\/\/doi.org\/10.1016\/j.neuron.2004.10.023","journal-title":"Neuron"},{"key":"2951_CR91","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/JPD-130192","volume":"3","author":"C Paisan-Ruiz","year":"2013","unstructured":"Paisan-Ruiz C, Lewis PA, Singleton AB (2013) LRRK2: cause, risk, and mechanism. J Parkinsons Dis 3:85\u2013103. https:\/\/doi.org\/10.3233\/JPD-130192","journal-title":"J Parkinsons Dis"},{"key":"2951_CR92","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41531-024-00660-y","volume":"10","author":"N Pena","year":"2024","unstructured":"Pena N, Richbourg T, Gonzalez-Hunt CP, Qi R, Wren P, Barlow C et al (2024) G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage. NPJ Parkinsons Dis 10:49. https:\/\/doi.org\/10.1038\/s41531-024-00660-y","journal-title":"NPJ Parkinsons Dis"},{"key":"2951_CR93","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-016-0292-9","volume":"4","author":"A Piras","year":"2016","unstructured":"Piras A, Collin L, Gruninger F, Graff C, Ronnback A (2016) Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol Commun 4:22. https:\/\/doi.org\/10.1186\/s40478-016-0292-9","journal-title":"Acta Neuropathol Commun"},{"key":"2951_CR94","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13073-017-0486-1","volume":"9","author":"PG Ridge","year":"2017","unstructured":"Ridge PG, Karch CM, Hsu S, Arano I, Teerlink CC, Ebbert MTW et al (2017) Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer\u2019s disease resilience. Genome Med 9:100. https:\/\/doi.org\/10.1186\/s13073-017-0486-1","journal-title":"Genome Med"},{"key":"2951_CR95","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha EM, De Miranda B, Sanders LH (2018) Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurobiol Dis 109:249\u2013257. https:\/\/doi.org\/10.1016\/j.nbd.2017.04.004","journal-title":"Neurobiol Dis"},{"key":"2951_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105360","volume":"154","author":"J Root","year":"2021","unstructured":"Root J, Merino P, Nuckols A, Johnson M, Kukar T (2021) Lysosome dysfunction as a cause of neurodegenerative diseases: lessons from frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol Dis 154:105360. https:\/\/doi.org\/10.1016\/j.nbd.2021.105360","journal-title":"Neurobiol Dis"},{"key":"2951_CR97","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1365-2990.2011.01216.x","volume":"38","author":"C Ruffmann","year":"2012","unstructured":"Ruffmann C, Giaccone G, Canesi M, Bramerio M, Goldwurm S, Gambacorta M et al (2012) Atypical tauopathy in a patient with LRRK2-G2019S mutation and tremor-dominant Parkinsonism. Neuropathol Appl Neurobiol 38:382\u2013386. https:\/\/doi.org\/10.1111\/j.1365-2990.2011.01216.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2951_CR98","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nbd.2017.12.005","volume":"111","author":"J Schapansky","year":"2018","unstructured":"Schapansky J, Khasnavis S, DeAndrade MP, Nardozzi JD, Falkson SR, Boyd JD et al (2018) Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble alpha-synuclein in neurons. Neurobiol Dis 111:26\u201335. https:\/\/doi.org\/10.1016\/j.nbd.2017.12.005","journal-title":"Neurobiol Dis"},{"key":"2951_CR99","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/s0197-4580(00)00110-x","volume":"21","author":"C Schwab","year":"2000","unstructured":"Schwab C, DeMaggio AJ, Ghoshal N, Binder LI, Kuret J, McGeer PL (2000) Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases. Neurobiol Aging 21:503\u2013510. https:\/\/doi.org\/10.1016\/s0197-4580(00)00110-x","journal-title":"Neurobiol Aging"},{"key":"2951_CR100","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/WAD.0000000000000643","volume":"38","author":"K Segers","year":"2024","unstructured":"Segers K, Benoit F, Levy S, Martinet V, Schulz JG, Bertrand F et al (2024) G2019S mutation of leucine-rich repeat kinase 2 is a cause of Lewy body dementia in patients with North African ancestors. Alzheimer Dis Assoc Disord 38:328\u2013331. https:\/\/doi.org\/10.1097\/WAD.0000000000000643","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2951_CR101","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00401-025-02872-9","volume":"149","author":"H Sekiya","year":"2025","unstructured":"Sekiya H, Franke L, Hashimoto Y, Takata M, Nishida K, Futamura N et al (2025) Widespread distribution of alpha-synuclein oligomers in LRRK2-related Parkinson\u2019s disease. Acta Neuropathol 149:42. https:\/\/doi.org\/10.1007\/s00401-025-02872-9","journal-title":"Acta Neuropathol"},{"key":"2951_CR102","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004485","volume":"4","author":"Z Sheng","year":"2012","unstructured":"Sheng Z, Zhang S, Bustos D, Kleinheinz T, Le Pichon CE, Dominguez SL et al (2012) Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations. Sci Transl Med 4:164ra161. https:\/\/doi.org\/10.1126\/scitranslmed.3004485","journal-title":"Sci Transl Med"},{"key":"2951_CR103","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1042\/BST20190236","volume":"49","author":"F Singh","year":"2021","unstructured":"Singh F, Ganley IG (2021) Parkinson\u2019s disease and mitophagy: an emerging role for LRRK2. Biochem Soc Trans 49:551\u2013562. https:\/\/doi.org\/10.1042\/BST20190236","journal-title":"Biochem Soc Trans"},{"key":"2951_CR104","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/brain\/aww214","volume":"139","author":"OA Skrobot","year":"2016","unstructured":"Skrobot OA, Attems J, Esiri M, Hortobagyi T, Ironside JW, Kalaria RN et al (2016) Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. Brain 139:2957\u20132969. https:\/\/doi.org\/10.1093\/brain\/aww214","journal-title":"Brain"},{"key":"2951_CR105","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1136\/jnnp-2019-321111","volume":"90","author":"C Smith","year":"2019","unstructured":"Smith C, Malek N, Grosset K, Cullen B, Gentleman S, Grosset DG (2019) Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry 90:1234\u20131243. https:\/\/doi.org\/10.1136\/jnnp-2019-321111","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2951_CR106","doi-asserted-by":"publisher","first-page":"1081426","DOI":"10.3389\/fncel.2022.1081426","volume":"16","author":"JK Smith","year":"2022","unstructured":"Smith JK, Mellick GD, Sykes AM (2022) The role of the endolysosomal pathway in alpha-synuclein pathogenesis in Parkinson\u2019s disease. Front Cell Neurosci 16:1081426. https:\/\/doi.org\/10.3389\/fncel.2022.1081426","journal-title":"Front Cell Neurosci"},{"key":"2951_CR107","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/nn1776","volume":"9","author":"WW Smith","year":"2006","unstructured":"Smith WW, Pei Z, Jiang H, Dawson VL, Dawson TM, Ross CA (2006) Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 9:1231\u20131233. https:\/\/doi.org\/10.1038\/nn1776","journal-title":"Nat Neurosci"},{"key":"2951_CR108","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1212\/01.wnl.0000239829.33936.73","volume":"67","author":"C Spanaki","year":"2006","unstructured":"Spanaki C, Latsoudis H, Plaitakis A (2006) LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP. Neurology 67:1518\u20131519. https:\/\/doi.org\/10.1212\/01.wnl.0000239829.33936.73","journal-title":"Neurology"},{"key":"2951_CR109","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31012","author":"M Steger","year":"2017","unstructured":"Steger M, Diez F, Dhekne HS, Lis P, Nirujogi RS, Karayel O et al (2017) Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis. Elife. https:\/\/doi.org\/10.7554\/eLife.31012","journal-title":"Elife"},{"key":"2951_CR110","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.12813","author":"M Steger","year":"2016","unstructured":"Steger M, Tonelli F, Ito G, Davies P, Trost M, Vetter M et al (2016) Phosphoproteomics reveals that Parkinson\u2019s disease kinase LRRK2 regulates a subset of Rab GTPases. Elife. https:\/\/doi.org\/10.7554\/eLife.12813","journal-title":"Elife"},{"key":"2951_CR111","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41531-022-00367-y","volume":"8","author":"T Tezuka","year":"2022","unstructured":"Tezuka T, Taniguchi D, Sano M, Shimada T, Oji Y, Tsunemi T et al (2022) Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson\u2019s disease. NPJ Parkinsons Dis 8:97. https:\/\/doi.org\/10.1038\/s41531-022-00367-y","journal-title":"NPJ Parkinsons Dis"},{"key":"2951_CR112","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00401-011-0871-6","volume":"122","author":"DR Thal","year":"2011","unstructured":"Thal DR, Del Tredici K, Ludolph AC, Hoozemans JJ, Rozemuller AJ, Braak H et al (2011) Stages of granulovacuolar degeneration: their relation to Alzheimer\u2019s disease and chronic stress response. Acta Neuropathol 122:577\u2013589. https:\/\/doi.org\/10.1007\/s00401-011-0871-6","journal-title":"Acta Neuropathol"},{"key":"2951_CR113","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/wnl.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800. https:\/\/doi.org\/10.1212\/wnl.58.12.1791","journal-title":"Neurology"},{"key":"2951_CR114","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41531-024-00690-6","volume":"10","author":"TF Tropea","year":"2024","unstructured":"Tropea TF, Hartstone W, Amari N, Baum D, Rick J, Suh E et al (2024) Genetic and phenotypic characterization of Parkinson\u2019s disease at the clinic-wide level. NPJ Parkinsons Dis 10:97. https:\/\/doi.org\/10.1038\/s41531-024-00690-6","journal-title":"NPJ Parkinsons Dis"},{"key":"2951_CR115","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1038\/s41467-020-19317-4","volume":"11","author":"H Trzeciakiewicz","year":"2020","unstructured":"Trzeciakiewicz H, Ajit D, Tseng JH, Chen Y, Ajit A, Tabassum Z et al (2020) An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline. Nat Commun 11:5522. https:\/\/doi.org\/10.1038\/s41467-020-19317-4","journal-title":"Nat Commun"},{"key":"2951_CR116","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12868-021-00687-4","volume":"23","author":"H Tu","year":"2022","unstructured":"Tu H, Zhang ZW, Qiu L, Lin Y, Jiang M, Chia SY et al (2022) Increased expression of pathological markers in Parkinson\u2019s disease dementia post-mortem brains compared to dementia with Lewy bodies. BMC Neurosci 23:3. https:\/\/doi.org\/10.1186\/s12868-021-00687-4","journal-title":"BMC Neurosci"},{"key":"2951_CR117","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00415-025-13148-3","volume":"272","author":"A Uchino","year":"2025","unstructured":"Uchino A, Hasegawa K, Yagishita S, Nagai M, Ogino M, Ogino Y et al (2025) Neuropathological examination of 12 cases of familial Parkinson\u2019s disease with LRRK2 I2020T mutation including tau and TDP-43 pathology. J Neurol 272:450. https:\/\/doi.org\/10.1007\/s00415-025-13148-3","journal-title":"J Neurol"},{"key":"2951_CR118","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.parkreldis.2012.03.024","volume":"18","author":"S Ujiie","year":"2012","unstructured":"Ujiie S, Hatano T, Kubo S, Imai S, Sato S, Uchihara T et al (2012) LRRK2 I2020T mutation is associated with tau pathology. Parkinsonism Relat Disord 18:819\u2013823. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.03.024","journal-title":"Parkinsonism Relat Disord"},{"key":"2951_CR119","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/01.jnen.0000218445.30535.6f","volume":"65","author":"U Unterberger","year":"2006","unstructured":"Unterberger U, Hoftberger R, Gelpi E, Flicker H, Budka H, Voigtlander T (2006) Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J Neuropathol Exp Neurol 65:348\u2013357. https:\/\/doi.org\/10.1097\/01.jnen.0000218445.30535.6f","journal-title":"J Neuropathol Exp Neurol"},{"key":"2951_CR120","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/cts.13541","volume":"16","author":"M Vissers","year":"2023","unstructured":"Vissers M, Troyer MD, Thijssen E, Pereira DR, Heuberger J, Groeneveld GJ et al (2023) A leucine-rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson\u2019s disease with and without LRRK2 mutations and healthy controls. Clin Transl Sci 16:1408\u20131420. https:\/\/doi.org\/10.1111\/cts.13541","journal-title":"Clin Transl Sci"},{"key":"2951_CR121","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1523\/JNEUROSCI.3642-15.2016","volume":"36","author":"LA Volpicelli-Daley","year":"2016","unstructured":"Volpicelli-Daley LA, Abdelmotilib H, Liu Z, Stoyka L, Daher JP, Milnerwood AJ et al (2016) G2019s-LRRK2 expression augments alpha-synuclein sequestration into inclusions in neurons. J Neurosci 36:7415\u20137427. https:\/\/doi.org\/10.1523\/JNEUROSCI.3642-15.2016","journal-title":"J Neurosci"},{"key":"2951_CR122","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","volume":"129","author":"L Walker","year":"2015","unstructured":"Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C et al (2015) Neuropathologically mixed Alzheimer\u2019s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol 129:729\u2013748. https:\/\/doi.org\/10.1007\/s00401-015-1406-3","journal-title":"Acta Neuropathol"},{"key":"2951_CR123","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.87255","author":"X Wang","year":"2023","unstructured":"Wang X, Bondar VV, Davis OB, Maloney MT, Agam M, Chin MY et al (2023) Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes. Elife. https:\/\/doi.org\/10.7554\/eLife.87255","journal-title":"Elife"},{"key":"2951_CR124","doi-asserted-by":"publisher","first-page":"12900","DOI":"10.1038\/s41598-021-91943-4","volume":"11","author":"X Wang","year":"2021","unstructured":"Wang X, Negrou E, Maloney MT, Bondar VV, Andrews SV, Montalban M et al (2021) Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10. Sci Rep 11:12900. https:\/\/doi.org\/10.1038\/s41598-021-91943-4","journal-title":"Sci Rep"},{"key":"2951_CR125","first-page":"245","volume":"53","author":"CD Ward","year":"1990","unstructured":"Ward CD, Gibb WR (1990) Research diagnostic criteria for Parkinson\u2019s disease. Adv Neurol 53:245\u2013249","journal-title":"Adv Neurol"},{"key":"2951_CR126","doi-asserted-by":"publisher","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA et al (2005) Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A 102:16842\u201316847. https:\/\/doi.org\/10.1073\/pnas.0507360102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2951_CR127","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s40478-020-00996-5","volume":"8","author":"VI Wiersma","year":"2020","unstructured":"Wiersma VI, Hoozemans JJM, Scheper W (2020) Untangling the origin and function of granulovacuolar degeneration bodies in neurodegenerative proteinopathies. Acta Neuropathol Commun 8:153. https:\/\/doi.org\/10.1186\/s40478-020-00996-5","journal-title":"Acta Neuropathol Commun"},{"key":"2951_CR128","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00401-019-02046-4","volume":"138","author":"VI Wiersma","year":"2019","unstructured":"Wiersma VI, van Ziel AM, Vazquez-Sanchez S, Nolle A, Berenjeno-Correa E, Bonaterra-Pastra A et al (2019) Granulovacuolar degeneration bodies are neuron-selective lysosomal structures induced by intracellular tau pathology. Acta Neuropathol 138:943\u2013970. https:\/\/doi.org\/10.1007\/s00401-019-02046-4","journal-title":"Acta Neuropathol"},{"key":"2951_CR129","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/JAD-180023","volume":"63","author":"T Yan","year":"2018","unstructured":"Yan T, Wang L, Gao J, Siedlak SL, Huntley ML, Termsarasab P et al (2018) Rab10 phosphorylation is a prominent pathological feature in Alzheimer\u2019s disease. J Alzheimers Dis 63:157\u2013165. https:\/\/doi.org\/10.3233\/JAD-180023","journal-title":"J Alzheimers Dis"},{"key":"2951_CR130","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315171120","volume":"120","author":"WM Yeshaw","year":"2023","unstructured":"Yeshaw WM, Adhikari A, Chiang CY, Dhekne HS, Wawro PS, Pfeffer SR (2023) Localization of PPM1H phosphatase tunes Parkinson\u2019s disease-linked LRRK2 kinase-mediated Rab GTPase phosphorylation and ciliogenesis. Proc Natl Acad Sci U S A 120:e2315171120. https:\/\/doi.org\/10.1073\/pnas.2315171120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2951_CR131","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC et al (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53:337\u2013351. https:\/\/doi.org\/10.1016\/j.neuron.2007.01.010","journal-title":"Neuron"},{"key":"2951_CR132","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-024-00738-4","volume":"19","author":"Y Yuan","year":"2024","unstructured":"Yuan Y, Li H, Sreeram K, Malankhanova T, Boddu R, Strader S et al (2024) Single molecule array measures of LRRK2 kinase activity in serum link Parkinson\u2019s disease severity to peripheral inflammation. Mol Neurodegener 19:47. https:\/\/doi.org\/10.1186\/s13024-024-00738-4","journal-title":"Mol Neurodegener"},{"key":"2951_CR133","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/brain\/awx344","volume":"141","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Perera G, Takahashi-Fujigasaki J, Mash DC, Vonsattel JPG, Uchino A et al (2018) Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers. Brain 141:486\u2013495. https:\/\/doi.org\/10.1093\/brain\/awx344","journal-title":"Brain"},{"key":"2951_CR134","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","volume":"89","author":"A Zimprich","year":"2011","unstructured":"Zimprich A, Benet-Pages A, Struhal W, Graf E, Eck SH, Offman MN et al (2011) A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet 89:168\u2013175. https:\/\/doi.org\/10.1016\/j.ajhg.2011.06.008","journal-title":"Am J Hum Genet"},{"key":"2951_CR135","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601\u2013607. https:\/\/doi.org\/10.1016\/j.neuron.2004.11.005","journal-title":"Neuron"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02951-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-025-02951-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02951-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:15:31Z","timestamp":1761225331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-025-02951-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":135,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2951"],"URL":"https:\/\/doi.org\/10.1007\/s00401-025-02951-x","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All donors and\/or next-of-kin had provided written informed consent for the use of autopsy material and clinical and genetic information for research purposes. All animal protocols were approved by Duke University\u2019s Institutional Animal Care and Use Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}}],"article-number":"44"}}